Mirum Pharmaceuticals MIRM SEC Filings

NASDAQ MIRM
$101.07 +0.44 (+0.44%)
As of: Sep 4, 2026 · 11:43 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Mirum Pharmaceuticals, Inc. (MIRM) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index